Contribution of plasma MicroRNA-21, MicroRNA-155 and circulating monocytes plasticity to childhood neuroblastoma development and induction treatment outcome
Pathology - Research and Practice · 2024-02 · 254 · 155060
DOI: 10.1016/j.prp.2023.155060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2024-02. Verfasst von Reham Hammad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pathology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt. Hauptthemen laut MEDLINE: MicroRNAs, Neuroblastoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Neuroblastoma (NB) accounts for 15% of all pediatric cancer fatalities (NB). Biomarkers that facilitate early NB detection are needed because by the time of diagnosis, over half of NBs had spread. MicroRNA-21(miR-21) and miR-155 are involved in cancer biology due to their immune modulation functions. Altered monocyte subset distribution is thought to be involved in a number of solid tumors due to its immunological role. We aimed to investigate the expression levels of miR-21 and miR-155 and their association with circulating monocytes subsets in NB and to evaluate if they correlate to the disease pathogenesis and outcome. PATIENTS AND METHODS: This case control study involved 79 children classified into 39 newly diagnosed NB children and 40 age and sex matched healthy children. Real-time PCR was used to assess the expression of plasma miR-21 and miR-155. The frequency of circulating monocytes subsets was assessed by flow cytometry. RESULTS: NB group showed significant up-regulation in expression of miR-21(20.9 folds) and miR-155 (1.8 folds) when compared to the control group (p < 0.001) and (p = 0.02) respectively. Also, frequency of circulating intermediate monocytes revealed significant up regulation in children with NB. In NB patients, there was a positive correlation between miR-21 and frequency of total and intermediate monocytes (r = 0.5 p < 0.001 and r = 0.7, p < 0.001, respectively). We found no discernible differences when we compared study markers between the high risk and intermediate risk groups. In addition, no significant difference was seen in study markers when patients were sub-grouped according to their induction treatment response. ROC curve analysis revealed that miR-21 up-regulation distinguished NB in childhood at an AUC of 0.94 (82% sensitivity and 100% specificity) while miR-155 up-regulation had less capacity to distinguish NB in childhood at an AUC of 0.65 (38% sensitivity and 93% specificity). CONCLUSION: miR-21 can be utilized as a sensitive biomarker for childhood NB development. In pediatric NB, miR-21 was linked to intermediate monocyte plasticity. Both, miR-21 and miR-155 had no impact on NB outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pathology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt.
- Pediatric Oncology Department, National Cancer Institute, Cairo University, Egypt.
- Clinical Pathology Department, Faculty of Medicine for Girls, Al-Azhar University, Cairo, Egypt. Electronic address: asmaaelmadbouly@azhar.edu.eg.
- Pharmacology Department, Faculty of Medicine (for Girls), Al-Azhar University, Egypt.
- Biochemistry & Molecular Biology Department, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo, Egypt.
Zitieren
APA
Hammad, R., Selim, M., Eldosoky, M. A., Elmadbouly, A. A., Abd El Hakam, F. E., Elshafei, A., Fawzy, M., & Hammad, M. (2024). Contribution of plasma MicroRNA-21, MicroRNA-155 and circulating monocytes plasticity to childhood neuroblastoma development and induction treatment outcome. Pathology - Research and Practice, 254, 155060. https://doi.org/10.1016/j.prp.2023.155060
Vancouver
Hammad R, Selim M, Eldosoky MA, Elmadbouly AA, Abd El Hakam FE, Elshafei A, et al. Contribution of plasma MicroRNA-21, MicroRNA-155 and circulating monocytes plasticity to childhood neuroblastoma development and induction treatment outcome. Pathology - Research and Practice. 2024;254:155060. doi:10.1016/j.prp.2023.155060
BibTeX
@article{Hammad2024,
author = {Hammad, Reham and Selim, Mustafa and Eldosoky, Mona A and Elmadbouly, Asmaa A and Abd El Hakam, Fatma El-Zahraa and Elshafei, Ahmed and Fawzy, Mohamed and Hammad, Mahmoud},
title = {Contribution of plasma MicroRNA-21, MicroRNA-155 and circulating monocytes plasticity to childhood neuroblastoma development and induction treatment outcome},
journal = {Pathology - Research and Practice},
year = {2024},
volume = {254},
pages = {155060},
doi = {10.1016/j.prp.2023.155060}
}
EUVIMED